Nan Shao 2025 Joint Meeting of the COSA ASM and IPOS Congress

Abstracts this author is presenting:

• Clinical proteome analysis identifies molecular signatures and diagnostic biomarkers between HER2-low and HER2-zero phenotypes in HR-negative breast cancer — Best of the Best Orals: Clinical research